Last updated: May 16, 2026
In this article
- Understanding Prostate Cancer in Dogs
- Tumor Types and How They Behave
- Risk Factors and Predisposed Breeds
- Recognizing the Warning Signs
- Diagnostic Workup
- Treatment Options
- Prognosis and Quality of Life
- Cost and Financial Reality
- Living with a Dog Diagnosed with Prostate Cancer
- Adoption and Senior Dog Realities
- Frequently Asked Questions
Understanding Prostate Cancer in Dogs
Prostate cancer in dogs is an uncommon but serious diagnosis that catches many owners by surprise. Unlike in human medicine where prostate cancer is one of the most-discussed cancers, canine prostate cancer is comparatively rare and tends to be diagnosed only after symptoms become prominent. The prostate gland sits at the base of the bladder, wrapped around the urethra, and contributes fluid to semen. When a tumor grows there, it can quickly affect both urination and defecation by compressing nearby structures.
One of the most counterintuitive points about prostate cancer in dogs is that neutering does not protect against it. This contrasts with benign prostatic hyperplasia (BPH), which is largely a problem of intact males and which neutering essentially cures. Prostate cancer affects intact and neutered males at similar rates, and some studies suggest that neutered males may even be at modestly higher risk. The reasons are not fully understood, but the practical message for owners is that any senior male dog, neutered or not, can develop this disease.
Tumor Types and How They Behave
The two most common malignant prostate tumors in dogs are prostatic adenocarcinoma, which arises from the glandular tissue of the prostate itself, and transitional cell carcinoma (TCC), which arises from the urothelial lining of the urethra and can extend into or originate within the prostatic urethra. Distinguishing the two requires histopathology, and treatment overlaps considerably between them.
Both are biologically aggressive cancers. Local invasion into the bladder, urethra, and pelvic structures is the rule rather than the exception, and metastasis to local lymph nodes, lungs, and bones is common. The bone metastases, particularly to the lumbar vertebrae and pelvis, can cause significant pain and mobility issues. For the closely related diagnosis in the urinary tract, see our transitional cell carcinoma in dogs article.
Risk Factors and Predisposed Breeds
Most affected dogs are middle-aged to senior, with the average age at diagnosis usually being older than nine years. Several breeds are over-represented in published case series, including Bouvier des Flandres, Doberman Pinschers, Shetland Sheepdogs, Scottish Terriers, Beagles, Miniature Poodles, and German Shorthaired Pointers. As with most cancers, breed predisposition is a risk modifier rather than a screening tool, and any senior male dog is potentially at risk.
Beyond age and breed, no clear environmental or dietary risk factor has been identified. Routine senior wellness exams, including digital rectal examination by your vet, are the practical screening approach. Pet insurance taken out before symptoms appear remains one of the strongest financial-protection tools owners have for any senior cancer diagnosis.
Recognizing the Warning Signs
Prostate cancer often presents with lower urinary and lower gastrointestinal signs. Difficulty urinating, straining, blood in the urine, dribbling, and recurrent urinary tract infections that don’t fully clear up are common. Many owners first notice that their dog is straining to defecate or producing flat, ribbon-like stools because the enlarged prostate is compressing the rectum. Constipation, tenesmus (straining to defecate), and pelvic discomfort are all part of the picture.
As the disease progresses or metastasizes, additional signs may appear. Lameness, particularly in the rear legs, can indicate bone metastasis or local nerve involvement. Weight loss, lethargy, and decreased appetite are nonspecific but common. Some dogs develop a stiff, painful gait that owners initially attribute to arthritis. Any senior male dog with persistent urinary or defecation difficulty deserves prompt veterinary evaluation rather than yet another empirical antibiotic course.
Diagnostic Workup
The workup typically begins with history, physical exam including digital rectal palpation of the prostate, and routine bloodwork plus urinalysis. Urine culture is important because secondary bacterial cystitis is common and can mask underlying disease. From there, imaging takes center stage. Abdominal ultrasound provides the best look at prostate architecture, identifies cysts or mineralization patterns suggestive of cancer, and screens for sublumbar lymph node enlargement. Mineralization in the prostate of a neutered male dog is a particularly suspicious finding because the prostate of a neutered dog should be small and mineralization-free.
Three-view chest radiographs and abdominal radiographs help with staging, particularly for lung and bone metastases. CT imaging is sometimes used for more detailed mapping. Definitive diagnosis requires tissue, typically obtained by ultrasound-guided fine-needle aspirate, traumatic catheterization for cytology, or surgical biopsy. Urine cytology and the BRAF mutation test (a urine-based PCR for transitional cell carcinoma) are useful adjuncts. Ask your primary vet for a referral to a board-certified oncologist (ACVIM-Oncology) once the diagnosis is suspected.
Treatment Options
Treatment of canine prostate cancer is rarely curative because most tumors are diagnosed at a locally advanced stage. The realistic goals of treatment are slowing progression, controlling symptoms, and preserving quality of life. Options include surgery, radiation therapy, chemotherapy, and medical management with NSAIDs.
Surgical options are limited. Total prostatectomy is technically possible but carries a high rate of urinary incontinence as a complication and is rarely curative on its own. Radiation therapy can be useful for local control and pain management, particularly for bone metastases. Chemotherapy, often with mitoxantrone or piroxicam-based protocols, is frequently part of the treatment plan. Piroxicam, a non-steroidal anti-inflammatory drug, has shown anti-tumor activity in transitional cell carcinoma and is commonly used in prostate cancer protocols.
Many treatment plans combine multiple modalities. The exact combination is tailored by your oncologist to the dog, the tumor type, the stage, and the family’s goals. Pain control is a priority throughout, often using NSAIDs alongside gabapentin or other adjuncts.
Prognosis and Quality of Life
Overall prognosis for prostate cancer in dogs is guarded. Without treatment, survival is typically measured in weeks to a few months from diagnosis. With multimodal treatment, many dogs gain meaningful additional time with good quality of life, though specific survival times vary considerably by stage and treatment. Your oncologist can give a realistic expectation based on your specific dog’s situation.
Quality-of-life conversations should happen early and often. A dog who is comfortable, eating well, urinating and defecating without distress, and engaging with the household is doing well by the most important measure. The ASPCA Pet Loss Hotline at 877-474-3310 is a resource for families navigating end-of-life decisions for cancer patients.
Cost and Financial Reality
Prostate cancer workup and treatment is expensive. Diagnostic imaging, biopsy, chemotherapy, possible surgery, radiation, hospitalizations, and follow-up visits can total many thousands of dollars over the course of treatment. Specific dollar figures vary by region and complexity. Ask your vet about cost ranges in your area, and consider CareCredit, scratchpay, payment plans, and rescue-side aid funds. Pet insurance bought before symptoms appear is the strongest tool for protecting against this kind of cost. Many oncology practices have client liaisons who can walk through projected costs at the start of treatment so families know what they are committing to.
Our veterinary specialist cost breakdown walks through realistic ranges for the kinds of services these cases need. Knowing the financial picture in advance helps families make decisions they can stick with.
Living with a Dog Diagnosed with Prostate Cancer
Day-to-day management focuses on comfort, hydration, and managing the lower urinary and lower GI signs that define this disease. A dog with prostate cancer often benefits from frequent short walks rather than long ones, easy access to a quiet outdoor toileting area, and a home setup that minimizes the need to navigate stairs or slick floors when mobility is affected by lameness or pelvic discomfort. Stool softeners are sometimes recommended when constipation is a problem; ask your vet before starting any over-the-counter product.
Recheck visits are an important part of treatment. Imaging is repeated every few months to monitor primary tumor size and screen for new metastasis. Bloodwork is monitored for chemotherapy side effects. Communicate any changes to your veterinary team promptly because adjustments to pain control, anti-nausea medications, or chemotherapy doses are often easier to make early.
Adoption and Senior Dog Realities
Senior dogs, particularly senior male dogs, are some of the most rewarding adoptions in any rescue, and they typically come fully grown, often house-trained, and ready to slot into a calm home. The senior cancer reality is real but should not deter prospective adopters who are otherwise prepared for a senior pet. Many cancers, including prostate cancer, allow for months or even years of meaningful life with appropriate care. Browse our adopt-a-dog hub to see senior dogs looking for soft landings.
For broader context on canine cancer, our cancer in dogs overview walks through the most common diagnoses and their warning signs. Working closely with your primary vet and getting referrals when needed remain the most important parts of senior-dog care. If you have an intact senior male dog, regular wellness exams that include a digital rectal exam are the practical screening approach. Bringing up urinary or defecation changes early, before they have been ongoing for months, helps ensure that diagnostic workup happens at a stage when more treatment options are still on the table.
Frequently Asked Questions
Does neutering prevent prostate cancer in dogs?
No. Neutering essentially cures benign prostatic hyperplasia, but prostate cancer affects intact and neutered males at similar rates. Some studies even suggest neutered males may be at modestly higher risk. Any senior male dog, regardless of neuter status, can develop the disease.
What are the first signs of prostate cancer in dogs?
Difficulty urinating or defecating, straining, blood in the urine, ribbon-like stools, recurrent urinary tract infections, and rear-leg lameness or stiffness are common early signs. Any persistent urinary or defecation difficulty in a senior male dog warrants veterinary evaluation.
Is prostate cancer in dogs curable?
Cure is rarely possible because most tumors are locally advanced at diagnosis. The realistic goals are slowing progression, controlling symptoms, and preserving quality of life. Multimodal treatment can give many dogs meaningful additional time.
How is prostate cancer diagnosed?
Diagnosis usually involves digital rectal exam, abdominal ultrasound, urinalysis with culture and cytology, the BRAF mutation urine test for TCC, biopsy or fine-needle aspirate, and chest radiographs for staging. CT imaging may also be used.
Can my dog be on piroxicam long-term?
Piroxicam is commonly used in canine prostate cancer protocols, but it carries a real risk of GI ulceration and kidney effects. Your vet will monitor closely with periodic bloodwork and adjust as needed. Never start or stop NSAIDs without veterinary guidance.